(Total Views: 40)
Posted On: 10/16/2025 8:37:46 AM
Post# of 39452
$PHRRF $PHRM News Out!! ~ PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson’s Disease
Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoing
Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoing
(0)
(0)
